₹152.3
▼ -2.56 -1.65%
As of 29 Jul 2026 · delayed
BSE Listed
Makers Laboratories Ltd. (506919)
Volume: 1,773Avg Vol 1W: 1,345Avg Vol 1M: 2,75152W Range:₹109₹186.7
Key Ratios
Checked 11h agoMarket Cap₹90 Cr
Current Price₹152.3
Previous Close₹154.86
High / Low (52w)₹186.7 / ₹109
Volume1,773
Avg Vol (1W)1,345
Avg Vol (1M)2,751
Stock P/E43.02
Book Value₹123.59
Dividend Yield0%
ROE322.43%
ROA472.33%
Revenue (TTM)—
Revenue Growth—
Profit Margin167.15%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹3.54
P/B1.23
Debt / Equity0.12
50 DMA₹152.79
200 DMA₹139.29
Day change-1.65%
Price Chart
₹152.3▲ 2.18% · 1Y
2025-07-292026-07-29
20-day avg volume: 3K shares
Pros
- Healthy return on equity of 322.4%.
- Company is almost debt-free.
- Revenue grew 1163% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹30 Cr | ₹30 Cr | ₹28 Cr | ₹34 Cr | ₹35 Cr | ₹34 Cr | ₹36 Cr | ₹36 Cr |
| EBITDA | ₹1 Cr | ₹11 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹5 Cr |
| Net Profit | ₹-1 Cr | ₹9 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9 Cr | ₹10 Cr | ₹133 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹142 Cr | ₹11 Cr |
| EBITDA | ₹-1 Cr | ₹-2 Cr | ₹15 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹12 Cr | ₹-1 Cr |
| Net Profit | ₹-1 Cr | ₹-1 Cr | ₹7 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹-1 Cr |
| EPS | — | — | 12.7 | — | — | — | 3.99 | — |
Balance Sheet
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | ₹136 Cr | ₹144 Cr | ₹152 Cr | ₹161 Cr | ₹148 Cr | ₹167 Cr |
| Total Liabilities | ₹50 Cr | ₹46 Cr | ₹43 Cr | ₹57 Cr | ₹33 Cr | ₹44 Cr |
| Equity | ₹87 Cr | ₹98 Cr | ₹110 Cr | ₹104 Cr | ₹115 Cr | ₹122 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | ₹24 Cr | ₹-6 Cr | ₹3 Cr | ₹-2 Cr | ₹18 Cr |
| Investing | ₹-22 Cr | ₹1 Cr | ₹-7 Cr | ₹20 Cr | ₹-15 Cr |
| Financing | ₹0 Cr | ₹6 Cr | ₹6 Cr | ₹-16 Cr | ₹0 Cr |
| Free Cash Flow | ₹24 Cr | ₹-6 Cr | ₹3 Cr | ₹-2 Cr | ₹18 Cr |
Shareholding
Promoter 61.27% Institutions 0.39% Public 38.34%
Efficiency & Working Capital
ROCE15.1%
Interest Coverage14.1
Dividend Payout—
Debtor Days52 d
Inventory Days117 d
Payable Days51 d
Cash Conversion Cycle117 d
Working Capital Days168 d
Shareholding Details
As of 2026-06-30
Promoter61.3%
FII0%
DII0.4%
Institutions0.4%
Public38.3%
Promoter Pledge0%
No. of Shareholders3,745
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% | 61.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.4% | 0% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Public | 38.3% | 38.7% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% | 38.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 4,283 | 4,179 | 4,176 | 4,090 | 4,008 | 4,031 | 4,135 | 4,073 | 4,026 | 3,926 | 3,801 | 3,745 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Kaygee Investments Private Limited | Shareholding of Promoter and Promoter Group | 36.9% | 21,75,859 |
| Kaygee Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 14.4% | 8,46,720 |
| Tanvi Jignesh Mehta | Public Shareholding | 2.3% | 1,35,254 |
| Premchand Godha | Shareholding of Promoter and Promoter Group | 2.2% | 1,27,033 |
| Prashant Godha | Shareholding of Promoter and Promoter Group | 2.1% | 1,22,937 |
| Nirmal Jain | Shareholding of Promoter and Promoter Group | 1.6% | 95,875 |
| Chandurkar Investments Private Limited | Shareholding of Promoter and Promoter Group | 1.4% | 84,411 |
| Ketan Damodhar Baheti | Public Shareholding | 1.1% | 67,000 |
| Usha Godha | Shareholding of Promoter and Promoter Group | 1% | 57,315 |
| Bhawna Godha | Shareholding of Promoter and Promoter Group | 0.7% | 42,206 |
| Usha M Chandurkar | Shareholding of Promoter and Promoter Group | 0.7% | 41,000 |
| Sameer M Chandurkar | Shareholding of Promoter and Promoter Group | 0.4% | 22,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| R K P Verma | Chairman & Independent Directo | 2026 |
| Saahil U Parikh | Non Independent Executive Director / WTD / CEO | 2026 |
| Nilesh Jain | Non Independent Executive Director / WTD | 2026 |
| Prashant Godha | Non-Exec & Non-Independent Dir | 2026 |
| Dipti Shah | Independent Non Exe. Director | 2026 |
| Vishal Jain | Independent Non Exe. Director | 2026 |
| Piyush Ajmera | Company Sec. & Compli. Officer | 2026 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 8 | 6 | 6 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-07 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 1 | 20 | 22 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 1 | 1 | 2 |
Insider / Designated-Person Trades
3 recent disclosure(s)
Kaygee Investments Pvt. Ltd.Acquisition · 11,50,579
Mexin Medicaments Pvt. Ltd.Disposal · 1,83,907
Paschim Chemicals Pvt. Ltd.Disposal · 9,66,672
Substantial Acquisitions (SAST)
1 disclosure(s)
Rights Issue09/05/2022 · 7,45,409
Company Information
Incorporated1984
ChairmanR K P Verma
AuditorNVC & Associates LLP
Investor Email[email protected]; [email protected]
📍 54 D Kandivli Industrial Estat, Charkop Kandivli (West), Mumbai, Maharashtra, 400067
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
AstraZeneca PharmaTANFAC Industries Ltd.Gujarat Petrosynthese Ltd.Swadeshi Industries & Leasing Ltd.Master Chemicals Ltd.Saptak Chem & Business Ltd.Continental Chemicals Ltd.J B Chemicals and PharmaceuticalsIndo Gulf Industries Ltd.Advance Petrochemicals Ltd.Rajasthan Petro Synthetics Ltd.APT Packaging Ltd.All “50” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search